Delivery Order SPE2DB24D9801-SPE2DB25FKYAM
- Not listed
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order for $2,004.99 under an indefinite delivery contract with the Defense Logistics Agency to supply Novolog 100 unit/ml Flexpen 3ml insulin injections. The delivery order is for fulfillment to Defense Logistics Agency Troop Support Medical facilities located in Park Ridge, Illinois, with performance to be completed by November 2, 2023. DMS Pharmaceutical Group holds additional delivery orders and an IDV through December...
- The Defense Logistics Agency Troop Support Medical awarded a $1,286 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for 100 unit/ml NovoLog FlexPen 3ml insulin devices. The order was placed under an indefinite-delivery/indefinite-quantity contract vehicle to supply pharmaceutical products and services to DOD customers. DMS Pharmaceutical Group will fulfill the order from its facility in Park Ridge, Illinois by September 26, 2023 to support DLA's medical supply chain initiatives....
- This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,265.00 firm fixed-price delivery order is for the supply of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a type of insulin medication. The contract has a period of performance through June 25, 2025 and was awarded on June 24, 2025. DMS Pharmaceutical Group Inc. has a significant single-award Indefinite...
- The Defense Logistics Agency Troop Support Medical has awarded a firm fixed price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide NOVOLOG 100 UNIT/ML FLEXPEN 3ML. The contract has a potential value of $1,891.50 and a completion date of January 17, 2024. DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler that provides a range of brand and generic pharmaceutical and medical supplies to the federal government, particularly the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $6,177.60 firm fixed-price delivery order is for NOVOLOG 100 UNIT/ML FLEXPEN 3ML medical supplies. The award is not associated with a set-aside program. DMS Pharmaceutical Group holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which...
- This federal contract award is a delivery order from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award, valued at $2,017.60, is for the supply of NOVOLOG 100 UNIT/ML VIAL 10ML, a pharmaceutical product. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. The...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $4,354.20, is for the delivery of 4,568,168,531 units of NOVOLOG 100 UNIT/ML FLEXPEN 3ML. The contract has an ultimate completion date of May 5, 2025 and was awarded on May 2, 2025. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, holding a...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a pharmaceutical product, with a ceiling value of $2,265.00 and an ultimate completion date of May 22, 2025. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $1,020.72 to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of 4563902919 NOVOLOG MIX 70-30 FLEXPEN 3ML. This delivery order is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and DLA, contract number 4600082013 under the SPE2DB program, valued at up to $4,999,999 through 2025. The IDC enables DLA to issue delivery orders for a...
- The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $1,650.63 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of insulin glargine-yfgn U100 pen 3mL to support the medical supply needs of military health facilities. This delivery order is issued under DMS Pharmaceutical Group's existing indefinite delivery vehicle (IDV) contract SPE2DB24D2106 with DLA, which has a ceiling...
- SPE2DB24D9801Indefinite Delivery Contract
- SPE2DB24D9801-SPE2DB25FKYAMDelivery Order
The Defense Logistics Agency awarded a $6,701.70 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for NovoLog 100 Unit/mL FlexPen 3mL insulin pens, with an ultimate completion date of July 23, 2025. This delivery order was issued without a set-aside designation and is being performed at the vendor's location in Park Ridge, Illinois. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, was selected to fulfill this requirement through its existing relationship with the federal government. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency, valued at $499,999,999 and extending through November 2026. The IDC enables the DLA to issue firm fixed-price delivery orders for pharmaceutical products supporting medical supply needs across military healthcare facilities nationwide. As a critical supplier in the federal pharmaceutical supply chain since 2001, DMS Pharmaceutical Group maintains a robust portfolio of contract awards covering prescription medications, biologics, vaccines, and specialized pharmaceutical products distributed to Department of Defense healthcare sites.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.7k | 7/22/25 |